Chapter 1416: Negotiations Finalized
"Welcome to the Chinese guests who have come from afar! The information of Lanrun's new drug product Fushen No. 1 has been carefully studied by Enke Pharmaceutical, and to be honest, it is also an honor to be the agent of Lanrun as a new drug channel agent. ”
Hardeman is a cheerful person, and he does not have as many twists and turns as Chinese businessmen, which is also the characteristic of most Europeans and Americans, refreshing and direct.
After clarifying his intentions, he continued: "We are willing to act as a channel agent for this new drug, but we have a little opinion on the channel fee sharing of cooperation...... Although Encore is not the top pharmaceutical channel in the world, it is also ranked among the top 50 in the world, and the main distribution channels are not only well-known in more than a dozen developed countries, but also in Africa and Australia also have certain outlets to promote. ”
In this case, Encore's distribution channels in the world should actually include more than 20 countries, so regarding the sharing of overseas agency channel fees, Encore hopes to get 60% of the product profit. ”
After saying this, Hardman laughed, staring intently at Qin Lang and the blue negotiation group, waiting for these guests from afar to express their opinions.
And Qin Lang and Tang Qian didn't directly pick up Hardeman's words, but seized the time and communicated with the other companions for a while.
In China, Lanrun Pharmaceutical directly sells new drugs to its partner Huairen Pharmaceutical Chain Group at the ex-factory price, and the subsequent market sales of drugs have nothing to do with Lanrun.
Overseas, in order to control risks, capitalists have a better way of agency, that is, cooperative management.
For example, in the cooperative operation model, after Qin Lang provides the new drug products as the product supplier, the channel provider Enke Pharmaceutical, as the exchanger, does not need to pay the purchase price immediately, but first sells the new drug products through the channel circulation market, and then settles with the supplier after generating profits.
The specific settlement method is to distribute the benefits generated by the new drug product proportionally after deducting the cost of the product and the capital consumption of the intermediate link.
Speaking of which, this model of sharing sales has certain benefits for both suppliers and channel providers.
On the supplier's side, the supplier seems to need a lot of capital costs to distribute the goods in advance, but then it participates in the operation of the channel provider, and if the sharing contract with the channel provider is negotiated, the money earned after that is definitely much more than directly selling drugs at the factory price.
On the channel provider's side, it is a zero-risk operation, which only needs to provide channels and revitalize the capital flow, in this case, as a channel provider, it can also spread the stall bigger, eliminating the possibility of capital breakage in the business process.
After studying for a while, Qin Lang shook his head at Hardeman at this time, and said: "After discussion, we Lanrun think that the result of six or four points is not very reasonable, our Lanrun Company has to bear a large number of product sales and sales risks, and spend a lot of money for overseas advertising and promotion, but in the end we can only get such a small amount of channel profit sharing, which is really not cost-effective." ”
"Moreover, the new drug of Fushen No. 1 has passed the test of the domestic market in China, and the overall response is good, and it can be expected that after the new drug is advertised and promoted, it will definitely be a round of explosive sales in the overseas market, so our opinion of Lanrun is that this distribution method should be reversed, and sixty percent of the profits of the product will go to Lanrun. ”
"Sixty percent of the profits go to Lanrun...... Doesn't that seem reasonable?" Hardeman was taken aback and quickly shook his head, he felt that Lan Run's people were really ruthless and bold enough.
In fact, Encore has been a channel agent for many years, and there is no precedent for only taking four components...... Besides, Encore seems to have no risk as a channel agent, but the cost of personnel and venues for channel operation is also very high, and of course it is necessary to strive for more benefits for itself.
Next, the two sides launched a fierce negotiation on the matter of channel sharing, and both sides held their nerve and made full use of all the negotiation skills in the modern business negotiation process.
This tug-of-war negotiation, Qin Lang next handed it over to Tang Qian and the negotiation team members to complete, after all, these people are more professional.
Drinking bitter black coffee, Qin Lang quietly closed his eyes and waited for the result of the negotiation.
After reaching the middle stage of the Yuan Infant Period, Qin Lang's current state of mind is becoming more and more elegant, and his temperament has also undergone some slight changes compared with the past.
This negotiation lasted for four or five hours, which shows that the whole negotiation is fierce and arduous, and the businessmen have always spared no effort in the pursuit of profits, so the two parties present have also tried their best to distribute profits between each other in the process of cooperation.
After that, the distribution of the channel share of "Fushen No. 1" was finally determined, and both parties made a step forward, and finally decided to divide the channel profit of the new drug by 55.
Both parties agreed to accept such a negotiation result, and the next step was to formally authorize and sign the contract.
Hardman dictated to his assistant, and then his assistant left, and after about a dozen minutes, the assistant returned with two contracts that had already been prepared.
These are two contracts in English, Tang Qian, as the main negotiator, and the team members read it carefully, and finally determined that there was no problem with the contract, and then put the contract in front of Qin Lang and asked Qin Lang to sign and authorize.
Although the negotiation process is very difficult, it is still relatively smooth, mainly because both parties are optimistic about the market prospects of the new drug "Fushen No. 1", so that everything can be negotiated smoothly.
After signing the contract, Qin Lang also breathed a sigh of relief, and then asked Tang Qian to contact Lanrun Pharmaceutical Factory to prepare and expand production.
Of course, the transfer of new drug products from Huaxia is only an expedient measure, and the customs declaration and transportation costs of the products are a large expense, and in the future, Qin Lang is likely to open pharmaceutical branches in Europe and the United States to reduce the cost of intermediate links of the product, in order to maximize the profit of the product.
But this is all for the future, to be honest, the most tight place in the whole Lanrun Pharmaceutical is the pharmaceutical factory.
Now Lanrun Pharmaceutical is just a grass creation, the domestic pharmaceutical factory is also expanding, the production capacity has not even been completed in the internal market of Huaxia, and now there is an additional overseas circulation channel, the current production line production capacity is completely insufficient, and it is also a coexistence of happiness and distress for the entire Lanrun Pharmaceutical.
However, Qin Lang is not very worried about the problem of insufficient production capacity of Lanrun Pharmaceutical Factory, and he also has his own solution.
Didn't you know so many giants at the last domestic pharmaceutical exchange meeting, and when the time comes, it is completely feasible to contact several giants and borrow the idle production lines of their respective pharmaceutical factories to speed up the production progress of new drugs.
Of course, the production line equipment under the giants may not be as advanced as Qin Lang, and the shipment efficiency and shipment volume of their respective production lines are much worse than the 500 million most advanced German production lines bought by Lanrun Pharmaceutical Factory, but at least half of the production capacity should be there.
Therefore, to solve the current problem of insufficient production capacity of Lanrun Pharmaceutical Factory, this is a wise strategy, this method fully illustrates the importance of connections in modern society, if Qin Lang had not met those Chinese pharmaceutical industry giants at the exchange meeting, he would not have thought of such a good way at all.
After signing the contract and a pleasant handshake, Hardeman booked a few tables at one of the best hotels in Los Angeles to celebrate the success of the partnership.
Qin Lang and his negotiators all attended this celebration banquet by appointment, and Enke Pharmaceutical also went to one or two dozen of them, including CEO Hardeman and several marketing department directors and other elite backbones.
Foreigners like to eat Western food, but Hardeman did the opposite this time, and actually ordered Chinese food, and naturally memorized the combination.
Not to mention, the Chinese food made by the chef of this six-star hotel called Sheraton is quite authentic, and many dishes are made to taste of hometown, which is really not simple.
However, the fly in the ointment is that these foreigners can't drink liquor, so they basically order red wine, and the strength of the red wine is so soft that even ordinary ladies can drink a few glasses, but this wine is very suitable to celebrate the success of the cooperation between the two sides.
"Cheers!"
"Cheers! ”
The two sides exchanged wines, and the celebration feast lasted more than an hour, and finally ended successfully in the celebration of these gringo gentlemen.
In the next ten days, Qin Lang's negotiation team did not return to Huaxia immediately after completing the task, but still stayed in Luoji to carry out a series of inspection activities, learn the operation and management experience of some foreign companies, and also conduct a new round of detailed investigation of their partner Enke Pharmaceutical to deepen their understanding.
The negotiation team is currently presided over by Tang Qian in daily activities, and Qin Lang left the negotiation team after he got the channel cooperation with Enke for new drugs, and instead contacted the twenty senior martial artists under his previous command.
The warrior team led by two ancient warriors came news one after another, and they had basically touched the headquarters of Reizman Group in country M, including the residence of the group's president Renault and several senior management, as well as the rules of daily actions.
Speaking of which, the twenty martial artists under Qin Lang really have the talent to be agents, and they have touched the entire headquarters of Rezman in the past few days, and the people on the other side may not have found out that someone is investigating them until now.
This is also the reason why these twenty martial artists have rich life experience, in fact, these martial artists above the late level of Wuzun are all over thirty years old, and their rich experience also makes their work style very mature and stable, which also makes Qin Lang feel very relieved.